The gut microbiota significantly influences metabolic health and immune system function, playing a pivotal role in the development of both type 1 and type 2 diabetes . Dysbiosis—imbalances in gut microbial composition—has been linked to increased intestinal permeability and systemic inflammation, contributing to insulin resistance in type 2 diabetes and autoimmune processes in type 1 diabetes. Emerging management strategies, such as dietary fiber intake, probiotic supplementation, and innovative therapies like fecal microbiota transplantation (FMT), show promise for improving glycemic control.
However, challenges remain, including study variability and the need for personalized microbiome-based interventions supported by robust clinical trials. To read more about the evolving role of gut microbiota in diabetes and therapeutic innovations, click here ##Reference## Krishna, Upadhye;…
